These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24085265)

  • 1. The bone resorption inhibitors odanacatib and alendronate affect post-osteoclastic events differently in ovariectomized rabbits.
    Jensen PR; Andersen TL; Pennypacker BL; Duong LT; Delaissé JM
    Calcif Tissue Int; 2014 Feb; 94(2):212-22. PubMed ID: 24085265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
    Vrahnas C; Buenzli PR; Pearson TA; Pennypacker BL; Tobin MJ; Bambery KR; Duong LT; Sims NA
    Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate.
    Muise ES; Podtelezhnikov AA; Pickarski M; Loboda A; Tan Y; Hu G; Thomspon JR; Duong le T
    J Bone Miner Res; 2016 Apr; 31(4):839-51. PubMed ID: 26587671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
    Duong LT; Pickarski M; Cusick T; Chen CM; Zhuo Y; Scott K; Samadfam R; Smith SY; Pennypacker BL
    Bone; 2016 Jul; 88():113-124. PubMed ID: 27126999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.
    Williams DS; McCracken PJ; Purcell M; Pickarski M; Mathers PD; Savitz AT; Szumiloski J; Jayakar RY; Somayajula S; Krause S; Brown K; Winkelmann CT; Scott BB; Cook L; Motzel SL; Hargreaves R; Evelhoch JL; Cabal A; Dardzinski BJ; Hangartner TN; Duong LT
    Bone; 2013 Oct; 56(2):489-96. PubMed ID: 23806798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
    Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
    J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
    Khan MP; Singh AK; Singh AK; Shrivastava P; Tiwari MC; Nagar GK; Bora HK; Parameswaran V; Sanyal S; Bellare JR; Chattopadhyay N
    J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible.
    Zhuo Y; Gauthier JY; Black WC; Percival MD; Duong LT
    Bone; 2014 Oct; 67():269-80. PubMed ID: 25038310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.
    Sims NA; Ng KW
    Curr Osteoporos Rep; 2014 Mar; 12(1):98-106. PubMed ID: 24477416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
    Pierroz DD; Bonnet N; Baldock PA; Ominsky MS; Stolina M; Kostenuik PJ; Ferrari SL
    J Biol Chem; 2010 Sep; 285(36):28164-73. PubMed ID: 20558734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits.
    Pennypacker BL; Duong LT; Cusick TE; Masarachia PJ; Gentile MA; Gauthier JY; Black WC; Scott BB; Samadfam R; Smith SY; Kimmel DB
    J Bone Miner Res; 2011 Feb; 26(2):252-62. PubMed ID: 20734451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently.
    Jensen PR; Andersen TL; Pennypacker BL; Duong LT; Engelholm LH; Delaissé JM
    Biochem Biophys Res Commun; 2014 Jan; 443(2):694-9. PubMed ID: 24333871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys.
    Masarachia PJ; Pennypacker BL; Pickarski M; Scott KR; Wesolowski GA; Smith SY; Samadfam R; Goetzmann JE; Scott BB; Kimmel DB; Duong LT
    J Bone Miner Res; 2012 Mar; 27(3):509-23. PubMed ID: 22113859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic implications of suppressing osteoclast formation versus function.
    Teitelbaum SL
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii61-ii63. PubMed ID: 27856662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey.
    Cusick T; Chen CM; Pennypacker BL; Pickarski M; Kimmel DB; Scott BB; Duong LT
    J Bone Miner Res; 2012 Mar; 27(3):524-37. PubMed ID: 22113921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
    Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
    Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of odanacatib in the treatment of osteoporosis.
    Ng KW
    Clin Interv Aging; 2012; 7():235-47. PubMed ID: 22866001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
    Sakai S; Endo K; Takeda S; Mihara M; Shiraishi A
    Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.
    Siebelt M; Waarsing JH; Groen HC; Müller C; Koelewijn SJ; de Blois E; Verhaar JA; de Jong M; Weinans H
    Bone; 2014 Sep; 66():163-70. PubMed ID: 24933343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.